Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Scientific Reports|August 9, 2022
Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancerChia-I Shen, Chi-Lu Chiang, Tsu-Hui Shiao, et al.
American Journal of Clinical Oncology|June 18, 2014
Erlotinib Salvage Therapy in Pulmonary Adenocarcinoma Patients With Disease Progression After Previous EGFR-TKI TreatmentWen-Shuo Wu, Chieh-Hung Wu, Shinn-Liang Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2011
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scanChao-Hua Chiu, Yi-Chen Yeh, Ko-Han Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
Osimertinib plus Selumetinib in EGFR-Mutated Non-Small Cell Lung Cancer After Progression on EGFR-TKIs: A Phase Ib, Open-Label, Multicenter Trial (TATTON Part B)James Chih-Hsin Yang, Yuichiro Ohe, Chao-Hua Chiu, et al.
Scientific Reports|August 10, 2021
Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancerChia-I Shen, Heng-Sheng Chao, Tsu-Hui Shiao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2011
Antagonism between gefitinib and cisplatin in non-small cell lung cancer cells: why randomized trials failed?Chun-Ming Tsai, Jen-Ting Chen, David J Stewart, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Erlotinib in patients with advanced lung squamous cell carcinomaChi-Lu Chiang, Chun-Ming Tsai, Teh-Ying Chou, et al.
The Annals of Thoracic Surgery|May 8, 2021
Sequence for Surgical Resection of Primary Lung Tumor for Oligometastatic Non-small Cell Lung CancerBor-Shiuan Shyr, Chien-Sheng Huang, Hui-Shan Chen, et al.
Frontiers in Medicine|April 8, 2022
Reduced FEV<sub>1</sub> as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint InhibitorsYi-Luen Shen, Chia-I Shen, Chi-Lu Chiang, et al.
Spinal Cord|September 11, 2019
Functional outcomes and survival after surgical stabilization for inoperable non-small-cell lung cancer with spinal metastasis of the thoracic and lumbar spines: a retrospective comparison between epidermal growth factor receptor-tyrosine kinase inhibitor and platinum-based chemotherapy groupsHsi-Hsien Lin, Chao-Hua Chiu, Po-Hsin Chou, et al.
Pageof 10